###begin article-title 0
Lack of association between angiotensin-converting enzyme and dementia of the Alzheimer's type in an elderly Arab population in Wadi Ara, Israel
###end article-title 0
###begin p 1
The angiotensin-converting enzyme (ACE), a protease involved in blood pressure regulation, has been implicated as an important candidate gene for Alzheimer's disease (AD). This study investigated whether the ACE gene insertion-deletion (ID) polymorphism is associated with risk of developing dementia of Alzheimer's type (DAT) in an Arab-Israeli community, a unique genetic isolate where there is a high prevalence of DAT. In contrast to several other studies, we found no evidence of an association between this polymorphism and either DAT or age-related cognitive decline (ARCD).
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 406 420 406 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Grossberg 2003</xref>
###xml 545 566 545 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Brookmeyer et al 2002</xref>
###xml 381 387 <span type="species:ncbi:9606">people</span>
###xml 470 477 <span type="species:ncbi:9606">persons</span>
###xml 516 523 <span type="species:ncbi:9606">persons</span>
Alzheimer's disease (AD) is a catastrophic affliction of the middle and later years of life. Clinically, it is marked by an irreversible decline in mental abilities, including progressive loss of memory, confusion, and dementia, and culminates in childlike helplessness. In the United States, the incidence of AD is exponentially increasing and is projected to affect 8.64 million people by the year 2047 (Grossberg 2003). Median survival times range from 8.3 years for persons diagnosed at age 65, to 3.4 years for persons diagnosed at age 90 (Brookmeyer et al 2002).
###end p 3
###begin p 4
###xml 447 460 441 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">Hu et al 2001</xref>
Angiotensin-converting enzyme (ACE) catalyzes the conversion of angiotensin I into a physiologically active peptide, angiotensin II. This reaction is an important process in blood pressure regulation. In addition to this well known physiologic role, ACE is able to cleave other proteins, including bradykinin and substance P, and has been shown to inhibit and cleave amyloid beta-peptide (Abeta) aggregation and amyloid plaque formation in vitro (Hu et al 2001). ACE may contribute to the pathogenesis of AD.
###end p 4
###begin p 5
###xml 297 316 297 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Bowirrat et al 2001</xref>
###xml 318 357 318 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Bowirrat, Friedland, Farrer, et al 2002</xref>
###xml 269 276 <span type="species:ncbi:9606">persons</span>
To test the hypothesis of association between ACE and DAT, we evaluated an insertion-deletion (ID) polymorphism in the ACE gene as a potential risk factor for dementia of the Alzheimer's type (DAT) in an Arab community in Wadi Ara, Israel. The population comprised 853 persons over the age of 65 (Bowirrat et al 2001; Bowirrat, Friedland, Farrer, et al 2002). Family studies revealed that more than one-third of DAT cases are members of one extended family. We hypothesized that DAT in Wadi Ara may be due to a founder effect enhanced by consanguinity; thus, a specific disease susceptibility allele may be overrepresented in cognitively impaired subjects compared with cognitively healthy residents. Our results suggest that the ACE-ID polymorphism is not associated with either DAT or age-related cognitive decline (ARCD) in this Arab community.
###end p 5
###begin title 6
Methods and results
###end title 6
###begin p 7
###xml 162 181 162 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Bowirrat et al 2001</xref>
###xml 1288 1307 1288 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Bowirrat et al 2001</xref>
###xml 1378 1386 1378 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">APA 1994</xref>
###xml 381 389 <span type="species:ncbi:9606">patients</span>
###xml 676 683 <span type="species:ncbi:9606">patient</span>
###xml 799 807 <span type="species:ncbi:9606">patients</span>
Subjects were sourced from a prevalence study of dementia conducted in Wadi Ara, a geographically defined area in northern Israel comprising three Arab villages (Bowirrat et al 2001). Among the original list of 853 residents aged 65 years and older (prevalence date, October, 1995), 823 (363 males and 460 females) were available and consented to participate in the study. Only 30 patients (23 females and 7 males) were excluded from the original list of the study (853) because they did not fulfill the diagnostic criteria for DAT and ARCD (they were classified with other medical conditions). Among the excluded females (n = 23), 19 suffered from vascular dementia (VaD), 1 patient had Parkinson's disease (PD), and 3 had pseudodementia. Among the excluded males (n = 7), 5 suffered from PD and 2 patients were diagnosed with VaD. The sex-specific prevalence of DAT among males and females was 53/363 = 14.6% and 115/460 = 25%, respectively; and the sex-specific prevalence of ARCD among males and females was 118/354 = 33.3% and 236/354 = 66.6%, respectively. These subjects were interviewed and examined by an Arabic-speaking neurologist (AB). Each subject underwent a battery of standard cognitive tests modified to fit the cultural and linguistic characteristics of this community (Bowirrat et al 2001). The diagnosis of DAT and ARCD was determined using DSM-IV criteria (APA 1994). Those with a medical history and laboratory or cognitive test results that suggested the presence of other illnesses, such as vascular dementia, Parkinson's disease, normal-pressure hydrocephalus, or pseudodementia (depression), were excluded. Peripheral blood samples were obtained from the 650 subjects for DNA analysis.
###end p 7
###begin p 8
###xml 884 885 882 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
To genotype the ACE-ID polymorphism, 2 polymerase chain reactions (PCRs) were performed. In the first reaction, primers that flank the ID polymorphism were used to amplify DNA from each subject (5'-CTGGAGACC ACTCCCATCCTTTCT and 5'-TTGATGAGTTCCAC GTATTTCG). The resulting PCR product was analyzed on a 2% agarose gel for the presence or absence of the 287-bp insertion-deletion polymorphism. Because this reaction frequently fails to detect the insertion variant, a second PCR reaction was performed that specifically amplifies the allele containing the insertion (primers 5'-CTGGGATTA CAGGCGTGATACA and 5'-TTGATGAGTTCCAC GTATTTCG). The data from both reactions were used to establish the ACE-ID genotype. For statistical analysis, the Hardy-Weinberg equilibrium (HWE) was assessed for each group (DAT, ARCD, normal). Allele and genotype frequencies were compared among groups by a chi2 test.
###end p 8
###begin p 9
###xml 40 47 40 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 464 471 464 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
The results of the ACE (ID) genotyping (Table 1) showed that the frequency of the I allele was 32% in cognitively normal control, 26% in DAT cases (p = 0.2223), and 32% in ARCD cases (p = 0.9559). The genotype frequency distribution in the control groups were also similar to those for DAT cases (p = 0.3731) and ARCD cases (p = 0.9973). Therefore, our results suggest that the ID polymorphism within ACE is not associated with DAT or ARCD in this Arab community (Table 1).
###end p 9
###begin p 10
Genotypic and allelic frequencies among ARCD, DAT, and cognitively normal control
###end p 10
###begin p 11
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abbreviations:</bold>
Abbreviations: ACE, angiotensin-converting enzyme; I, insertion allele; D, deletion allele; ARCD, age-related cognitive decline; DAT, dementia of Alzheimer's type; f(I), frequency of the insertion allele.
###end p 11
###begin title 12
Discussion
###end title 12
###begin p 13
AD is the most overdiagnosed and misdiagnosed disorder of mental functioning in older adults. Part of the problem, is that many other disorders show symptoms that resemble those of AD. The crucial difference, however, is that many of these disorders - unlike AD - may be stopped, reversed, or cured. Based on these findings, clinical diagnosis of AD has been referred to as "a diagnosis by exclusion", and one that can only be made in the face of clinical deterioration over time. There is no specific clinical test or finding that is unique to AD. Hence, all disorders that can bring on similar symptoms must be systematically excluded. The "classical" senile plaques and the neurofibrillary tangles seen in an AD brain at autopsy typically are the only definitive diagnosis of the disease.
###end p 13
###begin p 14
###xml 346 365 334 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">Bowirrat et al 2000</xref>
We did not observe an association between the ACE-ID polymorphism and DAT or ARCD in the elderly Arab population of Wadi Ara. Notably, inherited susceptibility for DAT in Wadi Ara is also not accounted for by the ApoE epsilon4 allele. Indeed, the frequency of ApoE epsilon4 among DAT, ARCD, and control was 0.027, 0.033, and 0.029, respectively (Bowirrat et al 2000).
###end p 14
###begin p 15
###xml 135 152 135 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Narain et al 2000</xref>
###xml 154 170 154 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">Cheng et al 2002</xref>
###xml 172 188 172 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Kehoe et al 2003</xref>
###xml 190 207 190 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">Elkins et al 2004</xref>
###xml 209 224 209 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Tian et al 2004</xref>
###xml 278 300 278 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">Myllykangas et al 2000</xref>
###xml 302 319 302 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Taylor et al 2001</xref>
###xml 321 336 321 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">Buss et al 2002</xref>
###xml 338 355 338 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Lendon et al 2002</xref>
###xml 357 377 357 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">Monastero et al 2002</xref>
###xml 379 396 379 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">Harrap et al 2003</xref>
###xml 398 414 398 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Panza et al 2003</xref>
###xml 534 552 534 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">Alvarez et al 1999</xref>
###xml 554 569 554 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">Yang et al 2000</xref>
###xml 571 584 571 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">Hu et al 2001</xref>
###xml 619 637 619 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Amouyel et al 1996</xref>
###xml 639 657 639 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Palumbo et al 1999</xref>
###xml 659 678 659 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Crawford et al 2000</xref>
###xml 680 697 680 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Farrer et al 2000</xref>
###xml 699 717 699 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">Richard et al 2001</xref>
Nonetheless, the relationship between ACE and AD is controversial. Several studies have implicated the ID polymorphism and risk of AD (Narain et al 2000; Cheng et al 2002; Kehoe et al 2003; Elkins et al 2004; Tian et al 2004), while other studies failed to find an association (Myllykangas et al 2000; Taylor et al 2001; Buss et al 2002; Lendon et al 2002; Monastero et al 2002; Harrap et al 2003; Panza et al 2003). Moreover, the pattern of association has been confusing, with some studies showing an association with the I allele (Alvarez et al 1999; Yang et al 2000; Hu et al 2001), while others with the D allele (Amouyel et al 1996; Palumbo et al 1999; Crawford et al 2000; Farrer et al 2000; Richard et al 2001).
###end p 15
###begin p 16
###xml 449 451 446 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">40</sub>
###xml 458 460 452 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">42</sub>
###xml 629 646 617 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">Lendon et al 2002</xref>
###xml 779 801 767 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">Myllykangas et al 2000</xref>
The reasons for the disparity in results across studies may be due to differences in ethnic background, different environmental factors, or subject misclassification. To date, few studies have examined the frequency of the ACE genotypes in autopsy-confirmed cases of AD, or investigated the potential effect of these ACE genotypes on the pathology of the disorder. In one autopsy series, the ACE genotype was not associated with the amount of A beta40, Abeta42, or pathological tau protein deposited within the frontal cortex, or in the extent of amyloid angiopathy in the brain, whether ApoE epsilon4 allele was present or not (Lendon et al 2002). The only other autopsy-based study of ACE (based on an elderly Finnish population) also failed to detect an association with ACE (Myllykangas et al 2000). In the Arab community, autopsy is prohibited for religious and traditional reasons. Other limitations of our study are the absence of biomarkers and complete biochemical examinations, and the low number of neuroimaging performed. These helpful clinical techniques are necessary to improve our clinical diagnosis of DAT and are required to differentiate it from similar clinical manifestation that mimic the presentation of dementia.
###end p 16
###begin p 17
###xml 260 277 260 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Rieder et al 1999</xref>
###xml 382 398 379 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Kehoe et al 2003</xref>
###xml 563 579 560 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">Zaman et al 2002</xref>
###xml 581 602 578 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">Hopkins and Hunt 2003</xref>
###xml 629 649 626 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">Arbustini et al 1995</xref>
###xml 651 667 648 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Kauma et al 1996</xref>
###xml 686 702 683 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Pfohl et al 1998</xref>
###xml 713 735 710 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">de la Torre et al 2002</xref>
###xml 773 791 770 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Alsaeid et al 2003</xref>
###xml 846 861 843 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">Ueda et al 1995</xref>
###xml 863 878 860 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">Hung et al 1999</xref>
###xml 880 897 877 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">Harrap et al 2003</xref>
A possible biological explanation for an association between ACE and AD is still unclear. The insertion allele appears to reduce ACE expression, and DD homozygotes and ID heterozygotes have more circulating ACE than II homozygotes: 65%, and 31%, respectively (Rieder et al 1999). This increased activity of the D allele may alter Abeta deposition by a direct proteolytic mechanism (Kehoe et al 2003). Alternatively, ACE may have an indirect role in the progression of AD. The ID polymorphism has also been implicated in various conditions including hypertension (Zaman et al 2002; Hopkins and Hunt 2003), coronary heart disease (Arbustini et al 1995; Kauma et al 1996), cardiomyopathy (Pfohl et al 1998), stroke (de la Torre et al 2002), and juvenile rheumatoid arthritis (Alsaeid et al 2003). Other studies don't confirm these associations (see Ueda et al 1995; Hung et al 1999; Harrap et al 2003).
###end p 17
###begin p 18
###xml 128 146 128 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Snowdon et al 1997</xref>
###xml 148 166 148 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">Zuliani et al 2001</xref>
###xml 168 201 168 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Bowirrat, Friedland, Korczyn 2002</xref>
###xml 203 219 203 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">de la Torre 2002</xref>
###xml 221 233 221 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">Korczyn 2002</xref>
###xml 658 691 658 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Bowirrat, Friedland, Korczyn 2002</xref>
###xml 833 855 833 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Fillit and Hill (2002)</xref>
###xml 759 767 <span type="species:ncbi:9606">patients</span>
###xml 810 818 <span type="species:ncbi:9606">patients</span>
Several studies suggest that there may be a relationship between cardiovascular lesions and the severity and progression of AD (Snowdon et al 1997; Zuliani et al 2001; Bowirrat, Friedland, Korczyn 2002; de la Torre 2002; Korczyn 2002). In summary, in the present study, we found a lack of association between ACE and DAT. Our previous studies have not determined any gene that may explain the high prevalence of DAT in this community, but we have found high prevalence of vascular dementia (VaD) following stroke. Indeed, the prevalence of VaD constitutes 5.9% of the total elderly Arab population in Wadi Ara and about 22% of the total dementia population (Bowirrat, Friedland, Korczyn 2002). This prevalence of VaD (22%) is extremely high compared with VaD patients who accounted for only 6% of all dementia patients identified by Fillit and Hill (2002). Given the role of the ACE gene in vascular disease as well as in AD, the ability to detect association with AD may be complex. On the other hand, and in light of the high frequency of VaD in this population, a new study to evaluate the role of ACE in VaD is essential.
###end p 18
###begin p 19
This work was supported in part by grants from the National Institute of Health (U01-AG17173), the Institute for the Study of Aging, NIAAA (R37-AA07112), and the US Department of Veterans Affairs.
###end p 19
###begin title 20
References
###end title 20
###begin article-title 21
Angiotensin converting enzyme gene insertion-deletion polymorphism is associated with juvenile rheumatoid arthritis
###end article-title 21
###begin article-title 22
Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease
###end article-title 22
###begin article-title 23
The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment
###end article-title 23
###begin article-title 24
Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction
###end article-title 24
###begin article-title 25
The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency
###end article-title 25
###begin article-title 26
Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs
###end article-title 26
###begin article-title 27
Vascular dementia among elderly Arabs in Wadi Ara
###end article-title 27
###begin article-title 28
Prevalence of Alzheimer's type dementia in an elderly Arab population
###end article-title 28
###begin article-title 29
Survival following a diagnosis of Alzheimer's disease
###end article-title 29
###begin article-title 30
No association between DCP1 genotype and late-onset Alzheimer's disease
###end article-title 30
###begin article-title 31
Study of the association between Alzheimer's disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes
###end article-title 31
###begin article-title 32
Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease
###end article-title 32
###begin article-title 33
Alzheimer's disease as a vascular disorder: nosological evidence
###end article-title 33
###begin article-title 34
Alzheimer's disease risk and genetic variation in ACE
###end article-title 34
###begin article-title 35
Association between angiotensin-converting enzyme and Alzheimer's disease
###end article-title 35
###begin article-title 36
The costs of vascular dementia: a comparison with Alzheimer's disease
###end article-title 36
###begin article-title 37
Diagnosis and treatment of Alzheimer's disease
###end article-title 37
###begin article-title 38
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition
###end article-title 38
###begin article-title 39
Genetics of hypertension
###end article-title 39
###begin article-title 40
Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (Abeta); retards Abeta aggregation, deposition, fibril formation; and inhibits cytotoxicity
###end article-title 40
###begin article-title 41
Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population
###end article-title 41
###begin article-title 42
Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis
###end article-title 42
###begin article-title 43
Haplotypes extending across ACE are associated with Alzheimer's disease
###end article-title 43
###begin article-title 44
Mixed dementia - the most common cause of dementia
###end article-title 44
###begin article-title 45
###xml 137 145 <span type="species:ncbi:9606">patients</span>
The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease
###end article-title 45
###begin article-title 46
Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease
###end article-title 46
###begin article-title 47
Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over
###end article-title 47
###begin article-title 48
The ACE gene and Alzheimer's disease susceptibility
###end article-title 48
###begin article-title 49
Angiotensin converting enzyme deletion allele in different kinds of dementia disorders
###end article-title 49
###begin article-title 50
Shifts in angiotensin I converting enzyme insertion allele frequency across Europe: implications for Alzheimer's disease risk
###end article-title 50
###begin article-title 51
Association between angiotensin I-converting enzyme genotypes, extracranial artery stenosis, and stroke
###end article-title 51
###begin article-title 52
The angiotensin I converting enzyme gene as a susceptibility factor for dementia
###end article-title 52
###begin article-title 53
###xml 26 31 <span type="species:ncbi:9606">human</span>
Sequence variation in the human angiotensin converting enzyme
###end article-title 53
###begin article-title 54
Brain infarction and the clinical expression of Alzheimer's disease. The Nun Study
###end article-title 54
###begin article-title 55
Alzheimer's disease not associated with polymorphism in the angiotensinogen and rennin genes
###end article-title 55
###begin article-title 56
A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease
###end article-title 56
###begin article-title 57
Lack of association between angiotensin-converting enzyme gene insertion/deletion polymorphism and stroke
###end article-title 57
###begin article-title 58
Association between angiotensin-converting enzyme gene and late onset Alzheimer's disease in Han Chinese
###end article-title 58
###begin article-title 59
Drugs targeting the rennin-angiotensin-aldesterone system
###end article-title 59
###begin article-title 60
Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia
###end article-title 60

